The Food and Drugs Monitoring Agency (BPOM) has greenlit the rollout of nearly half-a-million doses of the AstraZeneca COVID-19 vaccine, which were previously recalled for a toxicity analysis amid concerns of severe and fatal side effects.
In a written statement issued today, BPOM said the batch of 448,480 doses, code-named CTMAV547, can now be administered to the public.
“CTMAV547 has fulfilled quality standards and is safe for use,” the statement reads.
The batch was recalled less than two weeks ago for a thorough toxicity and sterilization testing by BPOM.
The recall came after three Indonesians died shortly after they received their jabs, but officials ruled out any definitive links between the vaccine and their deaths.
CTMAV547 was part of some 3.8 million doses of the AstraZeneca vaccine that arrived in Indonesia on April 26 as part of a WHO-backed initiative to distribute COVID-19 vaccines to developing countries. Some doses from the batch have been administered to military personnel and civilians in Jakarta and South Sulawesi.
BPOM says it will continue to monitor the safety and quality of all COVID-19 vaccines available in Indonesia.
Subscribe to The Coconuts Podcast for top trending news and pop culture from Southeast Asia and Hong Kong every Friday!